Naba Alsaha Medical Services Company (9546.SR) — Income statement
Revenue, gross profit, operating income, net income, and EPS for Naba Alsaha Medical Services Company — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 202↑3.9% | 194↑6.5% | 182↑40.6% | 130↑10.2% | 118 | |
| Cost of Revenue | 136↑2.8% | 132↑21.5% | 109↑39.1% | 78↑10.1% | 71 | |
| Gross Profit | 66↑6.1% | 62↓15.5% | 74↑42.9% | 52↑10.4% | 47 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 6↑26.2% | 5↓17.3% | 6↑38.1% | 4↓7.9% | 5 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 0.12↓99.5% | 24 | 0.00 | 0.00 | |
| SG&A Expenses | 6↓83.0% | 37↑23.0% | 30↑588.6% | 4↓7.9% | 5 | |
| Other Expenses | 29 | 0.00↓100.0% | 0.61↓96.8% | 19↑25.8% | 15 | |
| Operating Expenses | 35↓4.7% | 37↑20.6% | 31↑32.0% | 23↑17.8% | 20 | |
| Total Costs & Expenses | 171↑201.2% | -169↓221.3% | 139↑37.5% | 101↑11.8% | 91 | |
| Operating Results | ||||||
| Operating Income | 31↑22.1% | 25↓41.3% | 43↑51.8% | 28↑5.0% | 27 | |
| Depreciation & Amortization | 12↑7.0% | 11↑15.8% | 9↑40.3% | 7↑10.5% | 6 | |
| EBITDA | 43↑14.9% | 38↓42.2% | 65↑81.1% | 36↑6.3% | 34 | |
| EBIT | 32↑18.1% | 27↓51.8% | 55↑89.5% | 29↑5.0% | 28 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.93↑72.3% | 0.54↑186.5% | -0.62↓195.7% | -0.21↑15.1% | -0.25 | |
| Interest Income | 1↑41.7% | 0.73 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.10↓45.7% | 0.19↓69.7% | 0.62↑195.7% | 0.21↓15.1% | 0.25 | |
| Non-Operating Income | -0.77↑48.9% | -2↑87.9% | -13↓1191.8% | -0.97↓5.0% | -0.92 | |
| Other Income / Expenses | -0.16↓130.5% | 0.53↓95.5% | 12↑1809.2% | 0.62↑12.0% | 0.56 | |
| Income Before Tax | 31↑22.3% | 25↓54.3% | 55↑89.6% | 29↑5.1% | 28 | |
| Income Tax Expense | 3↓5.0% | 3↑32.0% | 2↑23.3% | 2↑18.2% | 2 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 28↑26.4% | 22↓58.4% | 52↑93.6% | 27↑4.7% | 26 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 28↑26.4% | 22↓58.4% | 52↑94.6% | 27↑4.2% | 26 | |
| Bottom-Line Net Income | 28↑26.4% | 22↓58.4% | 52↑94.6% | 27↑4.2% | 26 | |
| EPS (Basic) | 2.62↑26.6% | 2.07↓58.5% | 4.99↑94.9% | 2.56↑4.1% | 2.46 | |
| EPS (Diluted) | 2.62↑26.6% | 2.07↓58.5% | 4.99↑94.9% | 2.56↑4.1% | 2.46 | |
| Weighted Average Shares | 11↑0.1% | 11↑0.0% | 11↓0.0% | 11↑0.0% | 11 | |
| Weighted Average Diluted Shares | 11↑0.1% | 11↑0.0% | 11↓0.0% | 11↑0.0% | 11 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.